HOOKIPA Pharma Inc. (HOOK) News

HOOKIPA Pharma Inc. (HOOK): $1.00

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter HOOK News Items

HOOK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest HOOK News From Around the Web

Below are the latest news stories about HOOKIPA PHARMA INC that investors may wish to consider to help them evaluate HOOK as an investment opportunity.

Hookipa stock surges 46% on license deal with Roche for immunotherapy

Roche (OTCQX:RHHBY) (OTCQX:RHHBF) signed a license agreement with  Hookipa Pharma (NASDAQ:HOOK) to develop immunotherapy HB-700 for KRAS-mutated cancers and a second undisclosed novel arenaviral immunotherapy.

Under the agreement, Hookipa will receive $25M upfront. The Swiss pharma giant will have the option for an anothe...

Seeking Alpha | October 20, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4953 seconds.